Erectile dysfunction following radical cystectomy
ICD-10 N52.32 is a billable code used to indicate a diagnosis of erectile dysfunction following radical cystectomy.
Erectile dysfunction (ED) following radical cystectomy is a common complication that arises after surgical removal of the bladder, often due to cancer. The procedure can lead to nerve damage, vascular changes, and alterations in the anatomical structure of the pelvic region, all of which can impair erectile function. Patients may experience varying degrees of ED, from mild difficulties to complete inability to achieve or maintain an erection. The condition can significantly impact the quality of life, leading to psychological distress, relationship issues, and decreased sexual satisfaction. Management of ED post-cystectomy may involve pharmacological treatments, vacuum erection devices, penile injections, or surgical options such as penile prosthesis implantation. It is crucial for healthcare providers to address this issue proactively, as many patients may feel embarrassed to discuss sexual health concerns. Comprehensive assessment and tailored treatment plans are essential for restoring sexual function and improving overall well-being.
Detailed surgical history, including type of cystectomy and any nerve-sparing techniques used.
Patients presenting with ED after bladder cancer treatment, follow-up visits post-surgery.
Consideration of psychological factors and referral to sexual health specialists if needed.
Assessment of psychological impact of ED, including mental health evaluations.
Patients experiencing anxiety or depression related to sexual dysfunction.
Coordination with urology for comprehensive care.
Used for patients with severe ED post-cystectomy who have failed other treatments.
Document prior treatment attempts and patient consent.
Urology specialists should ensure comprehensive evaluations before proceeding.
The primary cause is nerve damage that occurs during the surgical procedure, which can impair blood flow and erectile function.
